Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Schizophrenia Bulletin|March 12, 2015
The promise of biological markers for treatment response in first-episode psychosis: a systematic reviewGuillaume Fond, Marc-Antoine d'Albis, Stéphane Jamain, et al.
Archives of General Psychiatry|May 9, 2012
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gainAnil K Malhotra, Christoph U Correll, Nabilah I Chowdhury, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
Psychotherapy and Psychosomatics|February 19, 2026
Identifying Transdiagnostic Predictors of Depression Across Psychoses: Informing Stratified Antidepressant TreatmentsSergio Mena, Fiona Coutts, Jana von Trott, et al.
The Lancet. Psychiatry|January 30, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)Inge Winter-van Rossum, Mark Weiser, Silvana Galderisi, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
Lancet (London, England)|April 1, 2008
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialRené S Kahn, W Wolfgang Fleischhacker, Han Boter, et al.
The Lancet. Psychiatry|October 18, 2020
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trialErik Johnsen, Rune A Kroken, Else-Marie Løberg, et al.
Frontiers in Psychiatry|February 17, 2022
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter StudySonia Dollfus, Armida Mucci, Giulia M Giordano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 1, 2019
A large European, multicenter, multinational validation study of the Brief Negative Symptom ScaleArmida Mucci, Annarita Vignapiano, István Bitter, et al.
Pageof 18